Trials / Completed
CompletedNCT00315523
Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen
Double-blind, 3 Parallel Randomized Groups, Therapeutic Confirmatory. Clinical Trial to Compare the Efficacy of Levocetirizine 5 mg and Montelukast 10 mg to Placebo in Reducing SAR Symptoms in Ragweed Sensitive Subjects in an EEC.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 403 (planned)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
To compare the clinical efficacy of levocetirizine 5 mg and montelukast 10 mg, administered once daily during two consecutive days, on symptoms of seasonal allergic rhinitis occurring in subjects exposed to ragweed pollen in an environmental exposure unit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levocetirizine |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2006-10-01
- Completion
- 2006-10-01
- First posted
- 2006-04-18
- Last updated
- 2013-12-16
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00315523. Inclusion in this directory is not an endorsement.